ES2121754T3 - Fragmento de adnc que codifica el gen del receptor del interferon alfa y procedimiento para la preparacion de una proteina correspondiente. - Google Patents

Fragmento de adnc que codifica el gen del receptor del interferon alfa y procedimiento para la preparacion de una proteina correspondiente.

Info

Publication number
ES2121754T3
ES2121754T3 ES90916311T ES90916311T ES2121754T3 ES 2121754 T3 ES2121754 T3 ES 2121754T3 ES 90916311 T ES90916311 T ES 90916311T ES 90916311 T ES90916311 T ES 90916311T ES 2121754 T3 ES2121754 T3 ES 2121754T3
Authority
ES
Spain
Prior art keywords
receptor
preparation
procedure
receptor gene
alpha interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90916311T
Other languages
English (en)
Inventor
Knud Erik Mogensen
Gilles Uze
Georges Lutfalla
Ion Gresser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROP BIOTECHNOLOGIE
Original Assignee
EUROP BIOTECHNOLOGIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9386616&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2121754(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by EUROP BIOTECHNOLOGIE filed Critical EUROP BIOTECHNOLOGIE
Application granted granted Critical
Publication of ES2121754T3 publication Critical patent/ES2121754T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7156—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL RECEPTOR DEL INTERFERON ALFA HUMANO Y A LA SECUENCIA DE ADN, EN PARTICULAR A UNA SECUENCIA DE ADNC, SE CARACTERIZA EN QUE CODIFICA EL GEN DEL RECEPTOR DEL INTERFERON ALFA. LA INVENCION SE REFIERE ADEMAS A LAS CELULAS NO HUMANOS QUE EXPRESAN DICHO RECEPTOR, UN PROCESO DE OBTENCION DE DICHAS CELULAS, UN PROCESO DE PREPARACION DE UNA PROTEINA QUE CORRESPONDE A DICHO FRAGMENTO DE ADN, LA PROTEINA ASI OBTENIDA, Y LOS ANTICUERPOS LEVANTADOS CONTRA ESTA PROTEINA. LA INVENCION SE REFIERE TAMBIEN A HITS DE DIAGNOSTICO A BASE DE DICHO RECEPTOR Y A LA UTILIZACION DE ESTE MISMO RECEPTOR PARA LA IDENTIFICACION DE AGONISTAS DE IFN ALFA HUMANO.
ES90916311T 1989-10-20 1990-10-19 Fragmento de adnc que codifica el gen del receptor del interferon alfa y procedimiento para la preparacion de una proteina correspondiente. Expired - Lifetime ES2121754T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898913770A FR2653445B1 (fr) 1989-10-20 1989-10-20 Fragment d'adnc codant pour le gene du recepteur de l'interferon alpha et procede de preparation d'une proteine correspondante.

Publications (1)

Publication Number Publication Date
ES2121754T3 true ES2121754T3 (es) 1998-12-16

Family

ID=9386616

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90916311T Expired - Lifetime ES2121754T3 (es) 1989-10-20 1990-10-19 Fragmento de adnc que codifica el gen del receptor del interferon alfa y procedimiento para la preparacion de una proteina correspondiente.

Country Status (8)

Country Link
EP (1) EP0495907B1 (es)
JP (1) JP3283509B2 (es)
AT (1) ATE169057T1 (es)
DE (1) DE69032526T2 (es)
DK (1) DK0495907T3 (es)
ES (1) ES2121754T3 (es)
FR (1) FR2653445B1 (es)
WO (1) WO1991005862A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889151A (en) * 1989-10-20 1999-03-30 Societe Leb-Tech Purified human alpha interferon receptor
EP0563487A1 (en) 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of the interferon-binding protein ALPHA / BETA
CA2171955A1 (en) * 1993-09-17 1995-03-23 Michael G. Tovey Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
CA2823468A1 (en) 2003-04-23 2004-11-04 Medarex, L.L.C. Compositions and methods for the therapy of inflammatory bowel disease
PL1781705T3 (pl) 2004-06-21 2015-03-31 Squibb & Sons Llc Antyciała receptora interferonów alfa I oraz ich zastosowania
HRP20240603T1 (hr) 2016-07-01 2024-07-19 Resolve Therapeutics, Llc Optimizirane fuzije binukleaze i postupci njihove upotrebe
CN111315767A (zh) 2017-08-22 2020-06-19 萨纳生物有限责任公司 可溶性干扰素受体及其用途

Also Published As

Publication number Publication date
DE69032526T2 (de) 1999-03-04
EP0495907B1 (fr) 1998-07-29
JPH05504468A (ja) 1993-07-15
DK0495907T3 (da) 1999-04-26
FR2653445B1 (fr) 1994-07-29
DE69032526D1 (de) 1998-09-03
EP0495907A1 (fr) 1992-07-29
ATE169057T1 (de) 1998-08-15
FR2653445A1 (fr) 1991-04-26
WO1991005862A1 (fr) 1991-05-02
JP3283509B2 (ja) 2002-05-20

Similar Documents

Publication Publication Date Title
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
DE69131249D1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
DK161015C (da) Blanding til anvendelse ved ekstern paavisning og lokalisering af en blodprop
MX9202875A (es) Una molecula de dna recombinante y procedimiento para su obtencion.
DK0980429T3 (da) Human Toll-lignende receptorproteiner, beslægtede reagenser og fremgangsmåder
DE3856301D1 (de) Dns sequenzen, rekombinante dns-moleküle sowie verfahren zur herstellung des an der lymphocyten-funktion assoziierten antigens-3
CO4600637A1 (es) Compuestos para inmunoterapia e inmunodiagnosis del cancer de prostata
ATE106940T1 (de) Für das polypeptid des t-zellantigenreceptors kodierende nukleinsäure.
ATE118352T1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
DE69617440D1 (de) Isolierte nukleinsäuremoleküle, peptide die mit hla-a2 moleküle (mhc) komplexe bilden, sowie deren verwendungen
DE3856180D1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
PT97574A (pt) Processo de obtencao de proteinas de superficie cd44 variaveis, sequencias do dna que as codificam, anticorpos destas proteinas, bem como a sua utilizacao no diagnostico e na terapia
ES2121754T3 (es) Fragmento de adnc que codifica el gen del receptor del interferon alfa y procedimiento para la preparacion de una proteina correspondiente.
DE69013811D1 (de) Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren.
AU7312801A (en) Compositions and methods for the diagnosis and treatment of herpes simplex virusinfection
SE8403377L (sv) Nya peptider
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
PT98073A (pt) Processo para a preparacao de polipeptidos contendo proteina macrofagica inflamatoria humana mip-2 beta por metodos recombinantes e de composicoes farmaceuticas que os contem
DK1287142T3 (da) Nukleinsyremolekyle omfattende en for et SDF-1 gamma chemokin, en neuropeptid-præcursor eller mindst et neuropeptid kodende nukleinsyresekvens
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
NO962596L (no) Nytt tumorsupressorgen
ES553374A0 (es) Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
ES2166757T3 (es) Secuencias de adn del virus de epstein-barr que codifican un antigeno de la capsida del virus de interes diagnostico, clones de expresion obtenidos por la reaccion en cadena de la polimerasa y el uso de este antigeno recombinante en ensayos de diagnostico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 495907

Country of ref document: ES